Biodegradable Cyclomatrix Polyphosphazene Nanoparticles: A Novel pH-Responsive Drug Self-Framed Delivery System

Area of Science:

• Nanotechnology
• Materials Science
• Pharmacology

Background:

• Traditional drug delivery systems often exhibit suboptimal drug-loading capacities and limited therapeutic effectiveness.
• There is a critical need for advanced drug delivery platforms that offer high efficiency and improved treatment outcomes.

Purpose of the Study:

• To develop an innovative drug delivery strategy, termed drug self-framed delivery system (DSFDS), that utilizes drugs as the primary structural component.
• To create biocompatible nanoparticles with high drug-loading capabilities and controlled release kinetics.

Main Methods:

• DSFDS nanoparticles were synthesized by reacting drug molecules with nucleophilic functional groups (e.g., doxorubicin with diols/diamines) with hexachlorocyclotriphosphazene.
• Mild precipitation polycondensation under ambient conditions was employed to form the nanoparticle structure.
• The stability and drug release characteristics of the synthesized nanoparticles were evaluated.

Main Results:

• Biocompatible drug self-framed delivery nanoparticles (DSFDs) were successfully formed with exceptionally high drug-loading due to covalent drug molecule integration.
• DSFDs demonstrated excellent stability within the circulatory system, preventing premature drug release.
• Sustained drug release was observed in the acidic intracellular environment, leading to prolonged therapeutic effects.

Conclusions:

• The drug self-framed delivery system (DSFDS) represents a novel strategy for creating high drug-loading, stable nanoparticles without external carriers.
• This approach offers a promising platform for developing advanced drug delivery systems with tunable release profiles for diverse drug types.
• DSFDS technology holds potential for enhancing anticancer therapy through sustained drug delivery and improved efficacy.